Status: Recruiting
Study of How People Make Decisions About Prostate Cancer Risk
The purpose of this study is to learn how people with BRCA1/2 mutations respond to genetic risk modifier testing. The researchers will learn more about how people make choices about their health care, including about methods to screen for prostate cancer. Researchers are also doing this study to learn about how the genetic risk modifier test affects people's thoughts and feelings.
Participants needed: 150
Trial details
Age: 45-70Biological sex: MaleType: ObservationalSponsor: Memorial Sloan Kettering Cancer CenterUpdated: Apr 22, 2026Locations: 1
Eligibility criteria
Documentation of Disease [+4]
Major psychiatric illness or cognitive impairment that in the judgment of the st... [+4]